hydralazine has been researched along with urapidil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Lewczuk, J; Wrabec, K | 1 |
| Abrouk, F; Adnot, S; Defouilloy, C; Kouzan, S; Lemaire, F | 1 |
| Rubin, LJ | 1 |
| Abrouk, F; Adnot, S; Brun-Buisson, C; Defouilloy, C; Lemaire, F; Piquet, J | 1 |
| Bachmann, R; Belz, G; Belz, GG; Graf, D; Matthews, JH; Palm, D; Steinijans, VW; Stern, HC | 1 |
| Bacher, S; Beck, A; Kraupp, O; Raberger, G; Seitelberger, R | 1 |
1 review(s) available for hydralazine and urapidil
| Article | Year |
|---|---|
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Evaluation; Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases, Obstructive; Piperazines; Prazosin; Pulmonary Heart Disease; Vasodilator Agents | 1991 |
2 trial(s) available for hydralazine and urapidil
| Article | Year |
|---|---|
Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Male; Middle Aged; Piperazines; Pulmonary Artery; Vascular Resistance | 1987 |
Dynamic responses to intravenous urapidil and dihydralazine in normal subjects.
Topics: Adult; Blood Pressure; Cardiography, Impedance; Clinical Trials as Topic; Dihydralazine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Piperazines; Random Allocation; Systole; Vascular Resistance | 1985 |
6 other study(ies) available for hydralazine and urapidil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Haemodynamic effects of urapidil compared to hydralazine in pulmonary hypertension.
Topics: Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Male; Oxygen; Piperazines | 1986 |
Vasodilators and pulmonary hypertension: where do we go from here?
Topics: Blood Pressure; Humans; Hydralazine; Hypertension, Pulmonary; Piperazines; Pulmonary Circulation; Vascular Resistance; Vasodilator Agents | 1987 |
Blood pressure response and renin release following 4 days of treatment with dihydralazine and urapidil in conscious dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dihydralazine; Dogs; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Rate; Hydralazine; Male; Piperazines; Renin; Time Factors | 1984 |